Cargando…
Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy
BACKGROUND: Photoimmunotherapy is one of the most promising strategies in tumor immunotherapies, but targeted delivery of photosensitizers and adjuvants to tumors remains a major challenge. Here, as a proof of concept, we describe bone marrow mesenchymal stem cell-derived nanovesicles (NVs) displayi...
Autores principales: | Chen, Hu, Zhang, Pengfei, Shi, Yesi, Liu, Chao, Zhou, Qianqian, Zeng, Yun, Cheng, Hongwei, Dai, Qixuan, Gao, Xing, Wang, Xiaoyong, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811970/ https://www.ncbi.nlm.nih.gov/pubmed/35109867 http://dx.doi.org/10.1186/s12951-022-01266-3 |
Ejemplares similares
-
Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody
por: Nagaya, Tadanobu, et al.
Publicado: (2016) -
Near infrared photoimmunotherapy with an anti-mesothelin antibody
por: Nagaya, Tadanobu, et al.
Publicado: (2016) -
PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model
por: Jin, Jiefu, et al.
Publicado: (2022) -
Photoimmunotherapy targeting biliary‐pancreatic cancer with humanized anti‐TROP2 antibody
por: Nishimura, Takashi, et al.
Publicado: (2019) -
Mace‐Like Plasmonic Au‐Pd Heterostructures Boost Near‐Infrared Photoimmunotherapy
por: Feng, Yanlin, et al.
Publicado: (2023)